2. 您的位置
3. 首页
4. 会议论文
5. The cyclin ECdk2p27Kip1 complex controls Myc activity and turnover at target promoters by regulating

The cyclin ECdk2p27Kip1 complex controls Myc activity and turnover at target promoters by regulating

来源 :2007年蛋白质修饰和降解北京国际研讨会(2007 International Symposium on Protein | 被引量 : 0次 | 上传用户：ZuoLuo

【作 者】

：

Su Yingtao Fuad Bahram Per Hydbring Natalie vonder Lehr Sara Fahlén Richard Lilischkis Bernhard Lüscher Lars-Gunnar Larsson 

【机 构】

：

Dept.ofMicrobiology,TumorandCellBiology(MTC),TheKarolinskaInstitute,SE-17177Stockholm;Dept.ofPlantBi

【出 处】

：

2007年蛋白质修饰和降解北京国际研讨会(2007 International Symposium on Protein

【发表日期】

：

2007年11期

【关键词】

：

c-Myc interferon p27Kip1 Cdk2 ubiquitin/proteasome pathway 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Atrogin-1Muscle atrophy F-box inhibits AKT-dependent cardiac hypertrophy via atypical ubiquitylation

会议

E3 ligase atrogin-1Foxol/3aUbiquitnationheart hypertrophy

Regulation of proteasomal degradation of certain substrates by ubiquitination and deubiquitination

会议

UbiquitinProteasomeApoptosisNrdp1BRUCE/Apollon

Ufd1 is a cofactor of gp78 and plays a key role in cholesterol metabolism by regulating the stabilit

会议

gp78Ufd1cholesterolHMG-CoA reductaseInsig-1

RNF5RMA1 and the 7 transmembrane protein JAMP-ER-anchored proteins which offer novel regulatory node

会议

Regulation of cell proliferation by a member of IAp family

会议

Effects of S-Nitrosylation in the Molecular Pathogenesis of Protein Misfolding and Neuronal Cell Dea

会议

c-Abl and Arg Tyrosine Kinases Regualtes Proteasomal Degradation and Chaperon Mediated Autophage of

会议

A Three Amino Acid Tail Following the TM4 Region of the N-Methyl-D-aspartate Receptor (NR) 2 Subunit

会议

Different active sites of proteasome as drug targets in cancer

会议

proteasomeinhibitordrug targestcancerubiquitin

Proteasome inhibitorlmatinib combinations exerts potentiated antileukemia efficacy but not cardiotox

会议

Proteasome inhibitorchronic myeloid leukemiaSTI571antileukemia efficacycardi